Home/Blog/Canine Hypothyroidism: NAVLE Study Guide
NAVLEEndocrine·⏱ 10 min read·📅 Mar 28, 2026·by NAVLE Exam Prep Team·👁 1
Canine Hypothyroidism: NAVLE Study Guide
Hypothyroidism is the most common endocrine disorder in dogs, and it shows up on the NAVLE constantly. The exam loves to test breed recognition, the TT4/fT4/cTSH triad, and the euthyroid sick syndrome trap. Get this one right and you pick up easy points.
What Actually Causes It
Two diseases account for nearly all cases. Lymphocytic thyroiditis (immune-mediated) destroys thyroid follicles over time – dogs often have detectable thyroglobulin autoantibodies years before clinical signs appear. Idiopathic follicular atrophy is the other major cause; the follicles just waste away with no immune component. Both produce the same result: inadequate T4 and T3 synthesis, with the pituitary compensating by cranking out TSH. That’s the pattern to recognize.
Secondary hypothyroidism (pituitary TSH deficiency) exists but is rare in dogs. If you see a question with low T4 AND low TSH, think secondary – or think euthyroid sick syndrome first, because that’s far more common.
Breed Predispositions
Middle-aged, medium-to-large breeds are the classic target. The highest-yield breeds for the exam: Golden Retrievers, Doberman Pinschers, Irish Setters, and Cocker Spaniels. If the question drops a 6–8-year-old Golden or Dobie with weight gain and alopecia, hypothyroidism should be at the top of your differential before you finish reading the question.
NAVLE Pearl
Sighthounds (Greyhounds, Salukis, Whippets) physiologically run low on total T4. A Greyhound with T4 of 0.7 µg/dL and normal TSH is normal for the breed, not hypothyroid. Use breed-specific reference ranges and always check TSH.
Clinical Signs to Know Cold
The classic presentation is a middle-aged dog with weight gain despite no increase in appetite, progressive lethargy, cold intolerance, and skin changes. The dermatological signs are the most NAVLE-testable:
Symmetric truncal alopecia – classically spares the head and distal extremities
“Rat tail” – alopecia of the dorsal tail with a rat-like appearance
Hyperpigmentation of alopecic skin
Myxedema – non-pitting facial edema from glycosaminoglycan accumulation; gives a “tragic face” appearance
Seborrhea sicca or oleosa, recurrent pyoderma
Cardiovascular: bradycardia is the key finding – hypothyroidism decreases heart rate and cardiac output. On labs, expect hypercholesterolemia (in roughly 75% of cases) and a mild normocytic, normochromic non-regenerative anemia.
Neurological complications are less common but testable: peripheral neuropathy, vestibular dysfunction (head tilt, nystagmus with normal otoscopic exam – think hypothyroid until proven otherwise), and cranial nerve deficits (CN VII facial palsy is classic). Megaesophagus has an established association with hypothyroidism and can resolve with levothyroxine treatment.
Diagnosis: The Three-Test Approach
This is the highest-yield diagnostic content on the NAVLE. You need to know what each test tells you and when to use it.
Test
Normal Range
In True Hypothyroidism
In Euthyroid Sick / Drug Effect
Total T4 (TT4)
1–4 µg/dL
Low (<0.5 strongly suggests; 0.5–1.5 = grey zone)
Also low – cannot distinguish from true hypothyroidism
Free T4 by ED (fT4-ED)
7–35 pmol/L
Low
Usually normal – most accurate single test
cTSH
0.05–0.42 ng/mL
Elevated – pituitary compensating
Normal or low
The money pattern on the NAVLE: low TT4 + low fT4-ED + elevated cTSH = primary hypothyroidism. All three together give you ~98% specificity. If TT4 is low but cTSH is normal, stop and reconsider – you’re probably looking at euthyroid sick syndrome.
When TT4 falls in the grey zone (0.5–1.5 µg/dL), always get fT4-ED and cTSH before treating. Do not start levothyroxine on a low-normal TT4 alone.
Classic NAVLE Trap
A sick, hospitalized dog with pyometra, liver disease, or any serious systemic illness will have a low TT4 from euthyroid sick syndrome – not hypothyroidism. The pituitary downregulates the HPT axis as part of the stress response. In a sick dog, a low TT4 with normal or low cTSH = euthyroid sick syndrome. Never diagnose hypothyroidism in a sick patient. Treat the underlying illness first and retest thyroid function when the dog is healthy.
Phenobarbital and other AEDs also suppress TT4. A dog on phenobarbital with a low TT4 but normal fT4-ED and normal cTSH is almost certainly euthyroid – the drug is altering protein binding and hepatic T4 metabolism, not causing real hypothyroidism.
Treatment and Monitoring
Start levothyroxine (L-T4) at 22 µg/kg PO q24h (some clinicians use 0.02 mg/kg q12h – both are acceptable). Give on an empty stomach when possible; food reduces absorption by roughly 30%.
Metabolic signs (lethargy, cold intolerance) improve within 1–2 weeks. Dermatological signs (alopecia, coat quality) take 3–6 months to fully resolve – this is a classic exam trap. Do not increase the dose at the 6-week recheck just because the coat hasn’t grown back. Check the post-pill T4 first.
NAVLE Tip
Monitor TT4 4–6 hours post-pill – this is the peak. Target: mid-to-high end of the normal range (2–4 µg/dL). Recheck at 4–8 weeks after starting therapy or after any dose change. If TT4 is >4 µg/dL at peak and the dog shows polyuria, polydipsia, weight loss, tachycardia, and restlessness, you’re looking at iatrogenic thyrotoxicosis – reduce the dose.
One special case: dogs with concurrent dilated cardiomyopathy (Dobermans come to mind). Start levothyroxine at 25–50% of the standard dose and titrate up slowly. Full standard dosing can precipitate cardiac decompensation by rapidly increasing myocardial oxygen demand.
Neurological and Cardiovascular Complications
These are hard questions on the NAVLE. Know the pattern: a dog with vestibular signs (head tilt, nystagmus, ataxia), a normal otoscopic exam, normal MRI, and hypercholesterolemia – run thyroid tests. Hypothyroid vestibular neuropathy can mimic idiopathic vestibular disease but often responds to levothyroxine over weeks to months.
Megaesophagus is an under-recognized association. If you see a dog with regurgitation and concurrent signs of hypothyroidism, hypothyroidism belongs on the differential list. It’s not the most common cause of megaesophagus, but it’s testable because treatment can reverse the esophageal dysfunction.
Myxedema Coma
Rare but boards-worthy because it’s dramatic. Profound obtundation or stupor, severe hypothermia (<96°F), bradycardia, hypotension, hypoventilation, and facial myxedema. This is an emergency. Treat with IV levothyroxine (oral absorption unreliable in critical patients), passive rewarming only (active rewarming can cause cardiovascular collapse), and supportive care. Do not rapidly rewarm – that’s the trap in the question.
Want full NAVLE study guides and timed practice questions?
Premium subscribers get condition-by-condition study guides, species-filtered practice questions, timed exam simulations, and a week-by-week study roadmap built for the boards.
Test yourself before moving on. Click an answer to reveal the explanation.
Question 1
A 7-year-old spayed female Golden Retriever presents with a 4-month history of lethargy, weight gain despite normal food intake, bilateral symmetric truncal alopecia, and a heart rate of 48 bpm. Serum cholesterol is 520 mg/dL. Total T4 is 0.4 µg/dL (reference 1–4 µg/dL). Which additional finding would MOST definitively confirm primary hypothyroidism?
Explanation
The combination of low TT4 + low fT4-ED + elevated cTSH provides approximately 98% specificity for primary hypothyroidism. The elevated cTSH confirms the pituitary is responding to inadequate thyroid hormone by upregulating TSH secretion, placing the lesion at the thyroid gland (primary). Option A (thyroglobulin autoantibodies) indicates lymphocytic thyroiditis may be present but does not confirm current hypothyroidism – many antibody-positive dogs remain euthyroid for years. Option C (low IGF-1) is associated with GH deficiency, not hypothyroidism. Option D (TRH stimulation) is technically unreliable and largely replaced by cTSH measurement. Option E (non-regenerative anemia) is consistent with hypothyroidism but is nonspecific and seen in many chronic diseases.
Question 2
An 8-year-old male neutered Labrador Retriever is hospitalized for pyometra. Routine bloodwork shows a total T4 of 0.6 µg/dL (reference 1–4 µg/dL) and a cTSH of 0.18 ng/mL (reference 0.05–0.42 ng/mL). The dog is alert and has no history of lethargy or skin changes. What is the most appropriate interpretation?
Explanation
This is the classic euthyroid sick syndrome scenario. Serious systemic illness (pyometra, liver disease, sepsis) downregulates the hypothalamic-pituitary-thyroid axis, causing a low TT4 in a dog that is actually euthyroid. The key clue is the normal cTSH – in true primary hypothyroidism, cTSH should be elevated because the pituitary has lost negative feedback. A low TT4 with a normal cTSH in a sick dog means euthyroid sick syndrome until proven otherwise. Never diagnose hypothyroidism in a sick patient, and never start levothyroxine based on thyroid testing performed during illness. Treat the underlying disease first and retest 4–8 weeks after recovery.
Question 3
A 6-year-old spayed female Doberman Pinscher with confirmed hypothyroidism has been on levothyroxine 22 µg/kg PO q24h for 6 weeks. The owner reports excellent improvement in energy level and activity, but the bilateral truncal alopecia and poor coat quality are unchanged. Post-pill TT4 measured 5 hours after dosing is 3.6 µg/dL. What is the most appropriate next step?
Explanation
Metabolic signs (lethargy, cold intolerance) respond within 1–2 weeks of starting levothyroxine. Dermatological signs – alopecia and coat quality – require full hair follicle cycling to reverse and take 3–6 months. The post-pill TT4 of 3.6 µg/dL at 5 hours is in the appropriate therapeutic target range (mid-to-high normal). Increasing the dose is incorrect and risks iatrogenic thyrotoxicosis. Liothyronine (T3) supplementation is not recommended – peripheral tissues convert T4 to T3 as needed, and exogenous T3 is harder to monitor with no additional benefit. The early metabolic improvement confirms the diagnosis is correct and the therapy is working.
Question 4
A 7-year-old male neutered Boxer presents with acute head tilt to the right, horizontal nystagmus with fast phase to the left, and ataxia. Otoscopic examination is normal bilaterally. MRI of the brain shows no structural abnormalities. Serum chemistry reveals hypercholesterolemia at 490 mg/dL. The dog has gained 4 kg over the past 6 months. Which condition should be investigated as the most likely underlying cause?
Explanation
Peripheral vestibular signs plus a normal otoscopic exam, normal MRI, hypercholesterolemia, and a history of weight gain should immediately trigger thyroid testing. Hypothyroidism can cause vestibular dysfunction via myxedematous deposits around the vestibulocochlear nerve, decreased vascular perfusion to the inner ear, and impaired axonal transport. The hypercholesterolemia (present in ~75% of hypothyroid dogs) is a critical clue. Idiopathic vestibular syndrome (Option A) is a diagnosis of exclusion and would not explain the hypercholesterolemia or weight gain. Option B is ruled out by normal otoscopy. Option D is unlikely given the normal MRI. Option E requires a specific exposure history. These vestibular signs can resolve with levothyroxine supplementation over weeks to months.
Question 5
A 9-year-old spayed female Labrador Retriever with a 3-year history of hypothyroidism controlled on levothyroxine presents with regurgitation of undigested food, progressive dysphagia, and episodes of aspiration pneumonia. Thoracic radiographs reveal diffuse esophageal dilation. Current post-pill TT4 (measured 5 hours after dosing) is 0.9 µg/dL. What is the most appropriate management?
Explanation
Megaesophagus is an established but underrecognized complication of hypothyroidism in dogs. The mechanism involves impaired neuromuscular function of the esophagus from thyroid hormone deficiency. Critically, this patient's post-pill TT4 of 0.9 µg/dL is below the therapeutic target of 2–4 µg/dL at peak (4–6 hours post-pill), indicating inadequate supplementation. Increasing the dose to achieve therapeutic TT4 levels may reverse or improve the megaesophagus – there are documented cases of megaesophagus resolution with adequate levothyroxine therapy. Option A is incorrect because hypothyroidism is a reversible cause that must be ruled out and treated before concluding the megaesophagus is idiopathic. Option C is factually wrong. Option D ignores the undertreated hypothyroidism. Option E has no evidence base – levothyroxine remains the standard of care.